C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
09/1994
09/07/1994	EP0613465A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
09/07/1994	CN1025855C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
09/06/1994	US5344963 Process for the production of substituted vinylbenzenes
09/06/1994	US5344925 Imidazolidyl macrolides having immunosuppressive activity
08/1994
08/31/1994	EP0612318A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
08/31/1994	EP0612313A1 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
08/30/1994	USRE34712 Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroiso benzofuran-5-carbonitrile and non-toxic acid addition salts thereof
08/30/1994	US5342941 Bronchodilating agents
08/30/1994	US5342838 Phenolic thioetheramides
08/24/1994	EP0533827B1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same
08/24/1994	CN1091135A Carbamates of rapamycin
08/23/1994	US5340822 Substance P, neurokinin antagonists
08/23/1994	US5340819 Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione
08/23/1994	US5340810 Benzanilide derivatives
08/23/1994	CA1331615C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
08/23/1994	CA1331614C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline- 3-carboxylic acids
08/16/1994	US5338754 Treating stroke or central nervous system disorders
08/10/1994	EP0609375A1 Novel 2,6-disubstituted purine derivatives
08/09/1994	US5336781 Aminating sulfonated indole derivatives
08/03/1994	CN1090279A Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
08/03/1994	CN1090272A New substituted azetidinones as anti-inflammatory and antidegenerative agents
08/02/1994	US5334604 Administering to mammals to lower glucose and/or cholesterol in the blood
08/02/1994	CA1331140C Agents for preserving or restoring the soundness of the skin
07/1994
07/27/1994	CN1089944A Benzanilide derivatives
07/26/1994	US5332748 Substituted derivatives of 20,21-dinoreburnamenine, their preparation process and the new intermediates thus obtained, their use as medicaments and the pharmaceutical compositions containing them
07/21/1994	WO1994015599A1 C10 taxane derivatives and pharmaceutical compositions
07/12/1994	US5329001 Substantially anhydrous crystalline cefadroxil and method for producing it
07/07/1994	WO1994014787A1 Novel sidechain-bearing taxanes and intermediates thereof
07/07/1994	WO1994014742A1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
07/07/1994	WO1994014436A1 Retroviral protease inhibiting compounds
07/06/1994	EP0605033A1 Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
07/06/1994	CN1025336C Process for 3-exomethylenecepham sulfoxide esters
07/05/1994	US5326874 Process for preparing trans-piperidine-2,5-dicarboxylates
06/1994
06/30/1994	CA2605872A1 Intermediates for retroviral protease inhibiting compounds
06/29/1994	CN1088576A 吲哚衍生物 Indole derivatives
06/29/1994	CN1025192C Azabicyclo quinolone carboxylic acids and the prepn. method therefor
06/23/1994	WO1994013676A1 Pyrrolopyrimidines as crf antagonists
06/23/1994	WO1994013652A1 Herbicides
06/23/1994	WO1994013645A1 Novel selective aromatase inhibiting compounds
06/23/1994	WO1994013644A1 Amino-substituted pyrazoles having crf antagonistic activity
06/23/1994	CA2150904A1 Novel selective aromatase inhibiting compounds
06/23/1994	CA2149530A1 Herbicides
06/22/1994	EP0205586B1 Composition comprising udpg and other anti-tumor drugs for treatment of tumors
06/22/1994	CA2111607A1 Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
06/09/1994	WO1994012505A1 Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
06/09/1994	WO1994012494A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists
06/09/1994	WO1994012492A1 Process for preparing benzopyran compounds
06/07/1994	US5318967 2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole derivatives
06/07/1994	US5318966 Administering the enzyme inhibitor for treating alzheimer's disease, learning enhancement, brain disorders
06/07/1994	US5318964 Hydroxamic derivatives and pharmaceutical compositions
06/01/1994	CN1087341A N-substituted azabicycloheptane derivatives, the preparation and use thereof
05/1994
05/26/1994	WO1994011361A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
05/26/1994	WO1994010996A1 Butenyl-substituted taxanes and composition
05/26/1994	DE4239150A1 O-acyl-4-phenyl-cyclohexanol derivs. - are inhibitors of 2,3-epoxy:squalene-lanosterol cyclase and useful as anti-hypercholesterolaemic for treating atherosclerosis
05/25/1994	EP0597956A1 Quinazoline derivatives as acetylcholinesterase inhibitors
05/25/1994	CN1087083A Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
05/25/1994	CN1024669C Cephem compound and process for preparation thereof
05/24/1994	US5314896 Dopaminergic agents, antipsychotic and hypotensive agents
05/18/1994	EP0597423A2 Azetidinone compound and process for preparation thereof
05/11/1994	WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents
05/11/1994	EP0463162B1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES
05/10/1994	US5310743 1-acylpiperidine compounds
05/04/1994	EP0595557A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents
05/04/1994	EP0594624A1 Dynemicin analogs: syntheses, methods of preparation and use
05/04/1994	CN1086219A Method of producing 5'-nucleotide
04/1994
04/26/1994	US5306726 Antidiabetic agents
04/26/1994	US5306717 Cephalosporin derivatives
04/26/1994	CA1328877C Antihypercholesterolemic agents
04/20/1994	EP0593227A1 Carbamates of rapamycin
04/20/1994	EP0592435A1 Process for the preparation of pyrimidine compounds
04/20/1994	CN1085553A Deoxy taxols
04/13/1994	EP0591355A1 Porphycene compounds for photodynamic therapy
04/13/1994	EP0591280A1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists
04/13/1994	CN1085212A 吲哚衍生物 Indole derivatives
04/12/1994	US5302584 Carbamates of rapamycin
04/12/1994	CA1328404C Pharmaceutical combination product and the preparation and use thereof
04/06/1994	EP0590267A2 Deoxy taxols
04/06/1994	EP0589975A1 New selective aromatase inhibiting 4(5)-imidazoles
04/06/1994	EP0589874A1 (s)(+)-2-ethoxy-4- n- 1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
04/02/1994	CA2100808A1 Deoxy paclitaxels
03/1994
03/31/1994	WO1994006792A1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
03/31/1994	CA2144158A1 Optically active hydroquinine 1-(3-aminophenyl)ethanesulfonate; preparation thereof and its use
03/29/1994	US5298514 Phenolic thioetheramides
03/29/1994	US5298507 Heterocyclic compounds
03/23/1994	CN1084174A Method of preparation of physostigmine carbamate derivatives from physostigmine
03/23/1994	CN1084171A Oxadiazine derivatives
03/22/1994	US5296620 Hexenol derivatives as intermediates for compounds for treatment of AIDS virus infections
03/22/1994	US5296214 Anticalculus composition
03/17/1994	WO1994005646A1 Optically active carboxamide derivative
03/17/1994	CA2143449A1 Optically active carboxamide derivative
03/15/1994	US5294710 N-5-protected 2,5-diamino-4,6-dichloropyrimidines and process for their production
03/10/1994	DE4243496A1 New di:peptide neurokinin antagonists - useful in treating respiratory disorders, inflammatory eye and skin disorders, polyarthritis, osteoarthritis and pain
03/08/1994	US5292748 Process for the production of substituted vinylbenzenes
03/08/1994	US5292740 Sulfonamides
03/02/1994	CN1083064A Substituted indolizino Û1,2-6Ù quinolinones
03/02/1994	CN1083062A 异羟肟酸衍生物 Hydroxamic acid derivatives
03/02/1994	CN1083059A 3-piperidinylmethylcarboxylate substituted indoles
03/02/1994	CN1083052A Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
03/01/1994	US5290929 Heteroaryl derivatives of monocyclic beta-lactam antibiotics
03/01/1994	US5290802 Analgesics, antiinflammatory agents, antiarthritic agents, prostaglandin, enzyme and interleukin inhibitors

1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 105